04-Dec-2013 - Soon to be merged CMO DSM Pharmaceutical Products (DPP) has been contracted to provide process development for a protein allergy drug being developed by Tunitas Therapeutics.
04-Dec-2013 - Pfizer says it is cutting 150 jobs and exiting its packaging operations at an Irish solid oral dose plant in order to increase competitiveness.
02-Dec-2013 - As part of its global streamlining strategy a second Irish Merck & Co plant has been earmarked to close but the firm says it remains committed to Ireland.
28-Nov-2013 - AstraZeneca was one of the first pharmaceutical companies in the world to adopt Toyota's 'lean manufacturing' methods. in-Pharmatechnologist.com visited the firm's plant in Södertälje to find out what impact this way of working is having on productivity.
27-Nov-2013 - Actavis says it is restructuring a Californian manufacturing facility at a cost of 56 jobs weeks after the announced closure of a plant in North Carolina.
25-Nov-2013 - Pfizer says it intends to shutter a manufacturing facility in Puerto Rico just days after Merck & Co. announced it was reducing its footprint on the island.
25-Nov-2013 - A £25m (€40.5m) investment at an API facility in Scotland will allow GSK closer control over its manufacturing network efficiency, the firm says.
18-Nov-2013 - AstraZeneca says it would never outsource the manufacture of Zoladex after announcing plans to invest £120m ($190m) in a fifth production facility for the blockbuster cancer drug.
13-Nov-2013 - The US FDA is working with GEA to validate continuous manufacturing as the pharma industry enters “the start of the end” for batch manufacturing, according to GEA.
12-Nov-2013 - There are multiple ways to make amorphous dispersions in order to enhance bioavailability but spray dry dispersion (SDD) is often the most applicable, Bend Research says.
11-Nov-2013 - Bend Research is expanding its commercial spray-dried dispersion (SDD) manufacturing with capital from new owners Capsugel in order to offer unique integrated capabilities, the firm says.
07-Nov-2013 - CatScI says pharma demand for catalysis services is increasing due to a greater focus on economic sustainability as it inks a deal with SAFC for its chemical processes.
07-Nov-2013 - The US FDA and European Medicines Agency (EMA) is now offering additional joint guidance on the concept of quality-by-design (QBD) that focuses mostly on design space verification.
06-Nov-2013 - Novartis has confirmed it is closing a UK facility as part of a global R&D review but remains silent on rumours specific business units will be divested.
04-Nov-2013 - Merck & Co intends to close ten more manufacturing plants to further shrink its footprint as it continues to restructure after its 2009 megamerger with Schering-Plough.
04-Nov-2013 - Copley Scientific expects the new version of its flow rate control technology for dry powder inhaler (DPI) testing to be in demand among both generic drug firms and pharmaceutical innovators.
29-Oct-2013 - GSK has teamed up with Brazilian researchers to develop ‘sustainable chemistry’ processes it will use to make drug manufacturing greener.
23-Oct-2013 - Indian manufacturing heavyweight Mylan Laboratories is looking to build off its major acquisition of Agila with a number of smaller acquisitions, while Natco is about to receive a cash infusion for manufacturing expansions.
22-Oct-2013 - Teva subsidiary Pliva has opened a new $100m (€73m) oral dosage manufacturing facility in Zagreb, Croatia to increase its export of tablets and capsules to the US and EU.
16-Oct-2013 - CMC Biologics has received renewal of its GMP credentials from the Danish Medicines Agency (DKMA) after upgrading the manufacturing capacity at its Copenhagen site.
15-Oct-2013 - Teva says 5,000 jobs will be lost next year as it accelerates its global cost reduction programme, set to save $2bn (€1.48bn) annually by 2017.
10-Oct-2013 - Lanxess backed enzyme and fine chemicals producer evocatal has moved to a new HQ, beefed up production capacity and is on the look out for new scientific staff.
09-Oct-2013 - Merck says it is shutting two New Jersey facilities as it moves its headquarters to the Kenilworth site where manufacturing ended last week.
04-Oct-2013 - Beleaguered sterile injectables manufacturer Ben Venue Laboratories has announced it will close permanently by the end of 2013 and lay off 1,100 employees in Ohio.
02-Oct-2013 - Cuts intending to save Merck & Co. up to $2.5bn (€1.85bn) will not affect manufacturing until after 2015, the firm says.
Dispatches from AAPS
The US FDA is working with GEA to validate continuous manufacturing as the pharma industry enters “the start...
The US FDA and European Medicines Agency (EMA) is now offering additional joint guidance on the concept...
Novartis has confirmed it is closing a UK facility as part of a global R&D review but...
In one of the largest healthcare fraud settlements in US history, Johnson & Johnson has pleaded guilty to...
The acquisition of Bend Research by Capsugel may be “a marriage made in heaven” for customers, the...